Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04988555
Status:
RECRUITING
Last Update Posted:
2024-01-18
First Post:
2021-07-26
Brief Title:
A Study of DSP-5336 in Relapsedrefractory AML ALL with or Without MLL Rearrangement or NPM1 Mutation
Sponsor:
Sumitomo Pharma America Inc
Organization:
Sumitomo Pharma America Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-26
First Submit QC Date:
July 26 2021
Study First Post Date:
2021-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-03
Last Update Post Date:
2024-01-18
Last Update Post Date Type:
ACTUAL